Chronic Hepatitis D Market Expected to Flourish from 2025-2034 with Innovative Therapies The Chronic Hepatitis D market is projected to witness substantial growth through 2034, driven by novel therapies and increased awareness of treatment options.

Chronic Hepatitis D Market Expected to Flourish from 2025-2034 with Innovative Therapies #None #Vir_Biotechnology #Chronic_Hepatitis_D #Bluejay_Therapeutics

Norgine Expands Hepatology and Specialty Portfolio with Exclusive Licensing Deal Norgine has secured an exclusive licensing agreement with Vir Biotechnology to expand its hepatology product offerings, addressing unmet medical needs.

Norgine Expands Hepatology and Specialty Portfolio with Exclusive Licensing Deal #United_Kingdom #Norgine #Uxbridge #Vir_Biotechnology #Chronic_Hepatitis_D